Osteoactivin inhibition of osteoclastogenesis is mediated through CD44-ERK signaling

Osteoactivin is a heavily glycosylated protein shown to have a role in bone remodeling. Previous studies from our lab have shown that mutation in Osteoactivin enhances osteoclast differentiation but inhibits their function. To date, a classical receptor and a signaling pathway for Osteoactivin-media...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Exp Mol Med
मुख्य लेखकों: Sondag, Gregory R, Mbimba, Thomas S, Moussa, Fouad M, Novak, Kimberly, Yu, Bing, Jaber, Fatima A, Abdelmagid, Samir M, Geldenhuys, Werner J, Safadi, Fayez F
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Nature Publishing Group 2016
विषय:
Original Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5050297/
https://ncbi.nlm.nih.gov/pubmed/27585719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emm.2016.78
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन